{
  "drug_name": "Bosentan",
  "url": "https://wikem.org/wiki/Bosentan",
  "scraped_at": "2026-01-10T03:02:59.314772",
  "sections": {
    "Adult_Dosing": {
      "text": "62.5-125mg PO BID",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "Safety/efficacy not established",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: X\nLactation risk: Infant risk cannot be ruled out\nRenal dosing:\nHepatic dosing: avoid in moderate-severe disease",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_pregnancy_categories"
        }
      ]
    },
    "Contraindications": {
      "text": "Allergy to class/drug\nConcomitant administration with cyclosporine A or glyburide\nPregnancy or potential pregnancy",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Anemia\nCirrhosis, liver failure\nOligozoospermia\nEdema, fluid retention",
          "tables": []
        },
        "Common": {
          "text": "Anemia\nRespiratory tract infection",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 5h\nMetabolism: Hepatic: via CYP3A4 and CYP2C9\nExcretion: Biliary, renal",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}